Hematologia

Revisão | Tratamento do tromboembolismo venoso na gestação.

14 Fev, 2022 | 15:44h

Management of venous thromboembolism in pregnancy – Thrombosis Research

Conteúdos relacionados:

Management of high-risk pulmonary embolism in pregnancy.

Study: Diagnosis of Pulmonary Embolism During Pregnancy

Imaging is the only way to diagnose blood clots in pregnancy

Prevention and Treatment of Pregnancy-Associated Venous Thromboembolism: Critical Appraisal of International Guidelines

---

Terapia genética com betibeglogene autotemcel para betatalassemia não-beta-0/beta-0.

14 Fev, 2022 | 15:39h

Betibeglogene Autotemcel Gene Therapy for Non–β⁰/β⁰ Genotype β-Thalassemia – New England Journal of Medicine (link para o resumo – $ para o texto completo)

 

Comentário no Twitter

Visual Abstract: Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia. https://t.co/2GOCGxrruv pic.twitter.com/zLvuuuByXN

— NEJM (@NEJM) February 8, 2022

 

---

Diretriz atualizada da IDSA para Covid-19 agora apoia o uso de plasma convalescente em pacientes ambulatoriais com COVID-19 leve a moderada sob alto risco de progressão para doença grave.

10 Fev, 2022 | 13:18h

IDSA Guidelines on the Treatment and Management of Patients with COVID-19 – Infectious Diseases Society of America

Conteúdo relacionado: [Preprint] RCT: In symptomatic adults above 18 years positive for SARS-CoV-2, early outpatient treatment with high-titer convalescent plasma significantly reduced hospitalizations.

 

Comentário no Twitter

Update Alert: Revised recommendation on the use of #convalescentplasma in ambulatory patients w/ COVID-19 at high risk of progression to severe disease w/ no other treatment options.

📄: https://t.co/YRCxtdilXT#COVID19Guidelines @JGPharmD @adarsh_bhimraj @RMKGandhi @ShohamTxID pic.twitter.com/KpXnywH362

— IDSA (@IDSAInfo) February 8, 2022

 

---

Diretrizes de consenso da Australásia para uso de agentes antifúngicos em hemato-oncologia.

10 Fev, 2022 | 13:05h

Introduction to the updated Australasian consensus guidelines for the management of invasive fungal disease and use of antifungal agents in the haematology/oncology setting, 2021

Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021

Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021

Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021

Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021

Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021

Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 2021

Consensus guidelines for improving patients’ understanding of invasive fungal disease and related risk prevention in the haematology/oncology setting, 2021

---

Consenso de especialistas | Algoritmo de tratamento da trombose associada a câncer.

10 Fev, 2022 | 13:02h

Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus – Current Oncology

---

Revisão | Transfusão pré-hospitalar de plasma: o que mostra a literatura?

10 Fev, 2022 | 12:47h

Prehospital Plasma Transfusion: What Does the Literature Show? – Transfusion Medicine and Hemotherapy

---

Revisão | Transfusão sanguínea de emergência no trauma e na ressuscitação perioperatória.

10 Fev, 2022 | 12:46h

Emergency Blood Transfusion for Trauma and Perioperative Resuscitation: Standard of Care – Transfusion Medicine and Hemotherapy

---

Em pacientes em uso de anticoagulantes (orais diretos ou warfarina), infecção de trato respiratório não tratada com antibióticos está associada com aumento de mais de 2 vezes no risco de sangramento nos 0-14 dias seguintes.

8 Fev, 2022 | 14:45h

Respiratory tract infection and risk of bleeding in oral anticoagulant users: self-controlled case series – The BMJ

 

Comentário no Twitter

In new research of 1208 oral anticoagulant users, a greater than twofold increase was seen in the risk of major bleeding & clinically relevant non-major bleeding in the 0-14 days after a respiratory tract infection for which no antibiotics were prescribed https://t.co/wMIb2eDBKk

— The BMJ (@bmj_latest) December 21, 2021

 

---

Coagulação intravascular disseminada (CIVD) na gestação: fisiopatologia, características clínicas, escores diagnósticos e tratamentos.

4 Fev, 2022 | 15:46h

DIC in Pregnancy – Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments – Journal of Blood Medicine

---

Revisão | Diagnóstico e tratamento do mieloma múltiplo.

4 Fev, 2022 | 15:31h

Diagnosis and Management of Multiple Myeloma: A Review – JAMA (gratuito por tempo limitado)

Revisão clínica em áudio: Diagnosis and Management of Multiple Myeloma – JAMA

---